ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
584 hedge funds and large institutions have $29.5B invested in Alexion Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 215 increasing their positions, 211 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 600 → 584 (-16)
14% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 69
Holders
584
Holding in Top 10
18
Calls
$257M
Puts
$256M
Top Buyers
| 1 | +$361M | |
| 2 | +$293M | |
| 3 | +$220M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$165M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$121M |
Top Sellers
| 1 | -$164M | |
| 2 | -$98.6M | |
| 3 | -$87.9M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$87.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$84.2M |